Todos los correos electrnicos de marketing incluyen una opcin de exclusin voluntaria
2.3%) and there was no difference in the percentage of participants with acute pancreatitis or malignant neoplasms between the two groups [110]
The schedule is a guideline, not a hard rule
Acta Pharm Sin B 2022;12:2443-61.ArticlePubMedPMC 116
Stay Informed Key dates to watch in 2026: TRIUMPH-1 and TRIUMPH-2 results (mid-2026), head-to-head retatrutide vs tirzepatide results (December 2026), and any NDA filing announcements from Eli Lilly
Primary Care Practitioners/Specialists (e.g., family physicians, nurse practitioners, gastroenterologists, endocrinologists, bariatric specialists, surgeons, endoscopists, dentists) Share the risk of aspiration associated with delayed gastric emptying and provide information about fasting and holding of the medication for all patients who are taking GLP-1 receptor agonists and undergoing procedures or imaging for which anesthesia is required
